<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref84">
 <mixed-citation publication-type="journal" id="cit84">
  <name>
   <surname>Bosch</surname>
   <given-names>B. J.</given-names>
  </name>; 
  <name>
   <surname>Martina</surname>
   <given-names>B. E. E.</given-names>
  </name>; 
  <name>
   <surname>van der Zee</surname>
   <given-names>R.</given-names>
  </name>; 
  <name>
   <surname>Lepault</surname>
   <given-names>J.</given-names>
  </name>; 
  <name>
   <surname>Haijema</surname>
   <given-names>B. J.</given-names>
  </name>; 
  <name>
   <surname>Versluis</surname>
   <given-names>C.</given-names>
  </name>; 
  <name>
   <surname>Heck</surname>
   <given-names>A. J. R.</given-names>
  </name>; 
  <name>
   <surname>de Groot</surname>
   <given-names>R.</given-names>
  </name>; 
  <name>
   <surname>Osterhaus</surname>
   <given-names>A. D. M. E.</given-names>
  </name>; 
  <name>
   <surname>Rottier</surname>
   <given-names>P. J. M.</given-names>
  </name>
  <article-title>Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides</article-title>. 
  <source>Proc. Natl. Acad. Sci. U. S. A.</source>
  <year>2004</year>, 
  <volume>101</volume>, 
  <fpage>8455</fpage>â€“
  <lpage>8460</lpage>. 
  <pub-id pub-id-type="doi">10.1073/pnas.0400576101</pub-id>.
  <pub-id pub-id-type="pmid">15150417</pub-id>
 </mixed-citation>
</ref>
